Tula Tube Delivery System (TDS)
Tusker Medical, Inc. · Decision date Jan 21, 2026
What did the FDA decide?
FDA records P190016/S011 as a supplement to PMA P190016, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jan 21, 2026.
FDA approval order statement
approval of a change in bacterial endotoxin testing (BET) from post-sterilization device samples to pre-sterilization device samples
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- Jan 21, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P190016/S011
- Regulatory pathway
- PMA supplement
- Applicant
- Tusker Medical, Inc.
- Product code
- QJA
- Decision code
- OK30
- Decision date
- Jan 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tympanostomy tube delivery product with drug.
- Applicant
- Tusker Medical, Inc.
- Product code
- QJA
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P190016/S010 · Related supplement
Tula System
P190016/S011 received
Application receipt date recorded by FDA.
P190016/S011 · FDA decision
30-Day Notice
P190016/S012 · Related supplement
Tula System
Timeline entries are records held by MedtechLedger for P190016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P190016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Tula SystemP190016/S010 | Tusker Medical, Inc. | PMA supplement | Oct 24, 2025 | FDA |
Tula SystemP190016/S012 | Tusker Medical, Inc. | PMA supplement | Jul 31, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tusker Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 155 Jefferson Dr., Suite 200, Menlo Park, CA, 94025
Sources and methodology
- Original FDA record: P190016/S011
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
